China's counterfeit medicine trade booming

Lewis, Katie
November 2009
CMAJ: Canadian Medical Association Journal;11/10/2009, Vol. 181 Issue 10, pE237
Academic Journal
The article presents a reprint of the article "China's counterfeit medicine trade booming," by Katie Lewis, which appeared at www.cmaj.ca on October 5, 2009. It notes that 600,000 counterfeit antimalarial tablets were intercepted by the Nigerian government which are from China. It states that drugs are not excluded in the counterfeit trade in the country which includes fake Gucci sunglasses. Moreover, Chinese suppliers were blamed for the contamination of heparin in the U.S in 2008.


Related Articles

  • Murder by fake drugs. Newton, Paul N; White, Nicholas J; Rozendaal, Jan A; Green, Michael D // BMJ: British Medical Journal (International Edition);4/6/2002, Vol. 324 Issue 7341, p800 

    Editorial. Focuses on the counterfeit drug trade. Mention of counterfeit representations of the antimalarials mefloquine and artesunate; Argument that the accumulated evidence suggests that mortality and morbidity arising from this murderous trade are considerable, especially in developing...

  • Counterfeit conundrum. Pavlou, Fedra // Pharmaceutical Technology Europe;Jul2010, Vol. 22 Issue 7, p6 

    In this article the author discusses the probable health risks of counterfeit medicines in Europe.

  • Counterfeit Cures. Cottrill, Ken // Traffic World;10/20/2003, Vol. 267 Issue 42, p18 

    Reports that the U.S. Food and Drug Administration (FDA) has created a task force to help improve the security of the pharmaceutical supply chain. Prevention of the sale of counterfeit drugs; Drug distribution models identified by the FDA; Weaknesses of existing distribution processes. INSET:...

  • Foreword: Globe-Hopping Pharmaceuticals. Miller, Frances H. // American Journal of Law & Medicine;2006, Vol. 32 Issue 2/3, p153 

    The article presents an overview of the topics being discussed regarding international regulatory issues in Pharmaceuticals. The topics include intellectual property dilemmas affecting global pharmaceuticals, parallel trade licit drugs between the U.S. and Canada , the increasing threat...

  • Pharmaceuticals Counterfeiting Drives Change. SCOTT, ALEX // Chemical Week;9/27/2010, Vol. 172 Issue 23, p48 

    The article highlights the efforts launched to address the increasing global prevalence of counterfeit medicines. Various industry sources claim that counterfeiting is prevalent in the pharmaceuticals supply chain. Guy Villax, head of Hovione, argues that tougher auditing of pharmaceutical...

  • London Creates Watch Dog for Fake Drugs.  // World Trade;Jan2003, Vol. 16 Issue 1, p16 

    Presents information on the initiative developed by London, England-based International Chamber of Commerce's Counterfeiting Intelligence Bureau that will help pharmaceutical companies solve the problem of counterfeit drugs. Ingredients of counterfeit drugs; List of fake pharmaceutical...

  • Current Challenges With Supply-Chain Integrity and the Threat to the Quality of Marketed Drugs. Paxton, M. // Clinical Pharmacology & Therapeutics;Feb2011, Vol. 89 Issue 2, p316 

    Counterfeits, illegal diversion, cargo thefts, and substandard drugs infiltrate pharmaceutical supply chains. This has been prevalent on a global basis but is now a growing problem in the United States. Manufacturers play a pivotal role in addressing this issue. However, while they are already...

  • New expression systems create opportunities for innovators, CMOS and product developers. Langer, Eric // Pharmaceutical Technology Europe;Jun2009, Vol. 21 Issue 6, p44 

    The article presents a reprint of the article "New Expression Systems Create Opportunities for Innovators, CMOs and Product Developers," by Eric Langer, which appeared in the March 2009 issue of "BioPharm International." It focuses on strategic innovation to address drug development processes in...

  • BIO 2010: QRxPharma begins end run. Dean, Tim // Australian Life Scientist;4/30/2010, p1 

    Sometimes the whole is greater than the sum of its parts. That's certainly the case with pharmaceutical company, QRxPharma. Not only does its lead product, MoxDuo, combine two existing drugs to give a superior effect with fewer side effects than current products, but the company has combined a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics